adefovir_dipivoxil: profile and news
Adefovir Dipivoxil Thwarts Recurrent Hepatitis B Virus Graft ... Apr 27, 2006
VIENNA, AUSTRIA -- April 27, 2006 -- The combination of adefovir dipivoxil (ADV, Hepsera R ) and lamivudine started before liver transplantation and continued ... - DG News
Adefovir Dipivoxil Provides Effective Prophylaxis Against ... Apr 28, 2006
New results document the safety and efficacy of the nucleotide analogue adefovir dipivoxil (ADV, HepseraR) for the prevention of graft re-infection in patients ... - Medical News Today (press release),
Independent Nurse: Clinical - Hepatitis B May 10, 2006
...gives passive protection. - Current pharmacological options include interferon-alfa, lamivudine and adefovir dipivoxil. Hepatitis B ... - Therapeutics Daily (subscription) (press release),
Increasing Drug Resistance to Widely Used Treatment for Hepatitis ... May 8, 2006
...report entitled Hepatitis B Virus finds that the uptake of Bristol-Myers Squibb's Baraclude (entecavir), Gilead's Hepsera (adefovir dipivoxil), and Novartis ... - PR Newswire (press release),
ΞΕÎ?Η ΔΗΜΟΣΙΕΥΣΗ-ΑÎ?ΑΚΟΙÎ?ΩΣΗ ΤΥΠΟΥ-PRN ... Apr 27, 2006
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med 2005;352(26):2673-81. [vii] Leung NW, Lai CL, Chang TT, et al. ... - Αθηναικο Î Ï?ακτοÏ?είο Ειδήσεων,
Gilead Sciences Announces First Quarter 2006 Financial Results Apr 18, 2006
...and tenofovir disoproxil fumarate) and Viread(R) (tenofovir disoproxil fumarate), as well as continued strong product sales for Hepsera(R) (adefovir dipivoxil ... - Genetic Engineering News,
The Navicor Group Named Agency of Record for Gilead's Hepsera Apr 24, 2006
...agency that focuses exclusively in the areas of oncology and immunology, has been named agency of record for Hepsera(r) (adefovir dipivoxil), an orally ... - PharmaLive.com (press release),
